PLAG1 and hepatocellular carcinoma: Our bioinformatics analysis, employing CRISPR-based screening, revealed a marked decrease in sgRNA targeting the oncogenic protein PLAG1 in HCC cells following treatment with ferroptosis inducers erastin and sorafenib.